NCT01791049View on ClinicalTrials.gov

TD-1607 SAD Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

October 31, 2013

Conditions
Serious Infections Due to Known or Suspected Gram-positive Pathogens
Interventions
DRUG

TD-1607

DRUG

Placebo

Trial Locations (1)

78744

PPD Phase 1, Austin

Sponsors
All Listed Sponsors
lead

Theravance Biopharma

INDUSTRY